ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
ABERRANT ANTIGEN PRESENTATION BY MACROPHAGES FROM TUMOR-BEARING MICE IS INVOLVED IN THE DOWN-REGULATION OF THEIR T-CELL RESPONSES
Author(s): WATSON GA, LOPEZ DM
Source: JOURNAL OF IMMUNOLOGY    Volume: 155    Issue: 6    Pages: 3124-3134    Published: SEP 15 1995  
Times Cited: 47     References: 26     
Abstract: Splenic T cells from BALB/c mice bearing mammary adenocarcinomas initially demonstrate a primed response to tumor-associated Ags (TAA), which declines to presensitization levels within 4 wk after tumor implantation. Associated with this decline in responses to TAA is the expansion of a subpopulation of Mac-1(+) 2(+) splenic macrophages (M phi). These Mac-1(+) 2(+) cells present TAA inefficiently to normal T cells primed to TAA by footpad injection, as compared with the Ag presenting ability of M phi from normal mice. The addition of anti-I-E(d), but not anti-I-A(d), Ab blocked the ability of Ag-pulsed Mac-1(+) 2(+) cells to present TAA to primed T cells. The converse was observed with macrophages from normal mice. However, presentation of human gamma-globulin or OVA was restricted by I-A(d) molecules when APC from normal mice or tumor bearers were used, although less efficiently in the latter. Using cell depletion techniques, it was determined that the I-E(d)-restricted presentation preferentially expanded CD8(+) T cells, and not CD4(+) cells, as was the case for I-A(d)-restricted normal macrophages. These CD8(+) cells were poor effecters of cytotoxicity against tumor cells; instead they down-regulated the proliferative activity of T cells. Limiting dilution assays indicated that Mac-1(+) 2(+) macrophages preferentially present TAA to a low frequency inhibitory T cell population that expanded and inhibited further responses to TAA. Thus, alterations of Ag presentation in tumor bearers may help the tumor to subvert potential beneficial host responses and allow the progression of the neoplastic process.
Document Type: Article
Language: English
Addresses:
1. UNIV MIAMI, SCH MED, DEPT MICROBIOL & IMMUNOL, MIAMI, FL 33101 USA
2. SYLVESTER COMPREHENS CANC CTR, MIAMI, FL 33136 USA
Publisher: AMER ASSOC IMMUNOLOGISTS, 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
Subject Category: Immunology
IDS Number: RU050
ISSN: 0022-1767
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo